Pak JS - Search Results

1

Interaction of patient age and high-grade prostate cancer on targeted biopsies of MRI suspicious lesions.

Pak JS, Huang R, Huang WC, Lepor H, Wysock JS, Taneja SS. Pak JS, et al. BJU Int. 2024 Jul;134(1):128-135. doi: 10.1111/bju.16341. Epub 2024 Mar 27. BJU Int. 2024. PMID: 38533536

2

Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active Surveillance.

Whalen MJ, Pak JS, Lascano D, Ahlborn D, Matulay JT, McKiernan JM, Benson MC, Wenske S. Whalen MJ, et al. Among authors: pak js. Clin Genitourin Cancer. 2018 Apr;16(2):e425-e435. doi: 10.1016/j.clgc.2017.10.007. Epub 2017 Oct 16. Clin Genitourin Cancer. 2018. PMID: 29113772

3

Diagnostic yield of repeat evaluation for asymptomatic microscopic hematuria after negative initial workup.

Pak JS, Wang EY, Lee K, Pina LA, McKiernan JM, Anderson CB. Pak JS, et al. Urol Oncol. 2021 May;39(5):300.e1-300.e6. doi: 10.1016/j.urolonc.2020.11.032. Epub 2020 Dec 15. Urol Oncol. 2021. PMID: 33339726

4

Editorial Comment.

Thakker S, Pak JS. Thakker S, et al. Among authors: pak js. J Urol. 2024 Jun;211(6):792-793. doi: 10.1097/JU.0000000000003942. Epub 2024 Apr 10. J Urol. 2024. PMID: 38598657 No abstract available.

5

A Novel Risk Prediction Model to Triage Difficult Urethral Catheterizations.

Ha AS, Pak J, Haas CR, Miles C, Weiner DM, Anderson CB, Badalato GM. Ha AS, et al. Urology. 2021 Nov;157:35-40. doi: 10.1016/j.urology.2021.05.059. Epub 2021 Jun 18. Urology. 2021. PMID: 34153365

6

Delay from biopsy to radical prostatectomy influences the rate of adverse pathologic outcomes.

Berg WT, Danzig MR, Pak JS, Korets R, RoyChoudhury A, Hruby G, Benson MC, McKiernan JM, Badani KK. Berg WT, et al. Among authors: pak js. Prostate. 2015 Jul 1;75(10):1085-91. doi: 10.1002/pros.22992. Epub 2015 Mar 21. Prostate. 2015. PMID: 25809289

7

Invited Commentary: Inguinal Lymph Node Dissection: How Are We Doing?

Pak JS, Tan WP. Pak JS, et al. J Am Coll Surg. 2023 Jan 1;236(1):25-26. doi: 10.1097/XCS.0000000000000444. Epub 2022 Dec 15. J Am Coll Surg. 2023. PMID: 36519903 No abstract available.

8

Utilization trends and outcomes up to 3 months of open, laparoscopic, and robotic partial nephrectomy.

Pak JS, Lee JJ, Bilal K, Finkelstein M, Palese MA. Pak JS, et al. J Robot Surg. 2017 Jun;11(2):223-229. doi: 10.1007/s11701-016-0650-4. Epub 2016 Nov 1. J Robot Surg. 2017. PMID: 27804062

9

Utilization and Perioperative Outcomes of Partial Cystectomy for Urothelial Carcinoma of the Bladder: Lessons from the ACS NSQIP Database.

Whalen MJ, Danzig MR, Pak JS, Alberts BD, Badani KK, DeCastro GJ, McKiernan JM. Whalen MJ, et al. Among authors: pak js. Urol Pract. 2015 May;2(3):109-114. doi: 10.1016/j.urpr.2014.10.003. Epub 2015 Feb 26. Urol Pract. 2015. PMID: 37559270

10

Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations.

Joffe BI, Christin JR, Le Coz C, Gorroochurn P, Pak JS, Laplaca C, Reyes HV, DeCastro GJ, Anderson CB, Abate-Shen C, Shen MM, McKiernan JM, Lenis AT. Joffe BI, et al. Among authors: pak js. Urol Oncol. 2025 Oct;43(10):594.e1-594.e7. doi: 10.1016/j.urolonc.2025.05.012. Epub 2025 Jun 7. Urol Oncol. 2025. PMID: 40484780

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters